Notably, prior studies have reported that fibrotic lung fibroblasts from patients with IPF and from mice following intratracheal bleomycin have decreased cell surface Fas when compared to normal lung fibroblasts [13, 14]. The gene discussed is FAS; the disease is idiopathic pulmonary fibrosis.